Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Prünte

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Acta Ophthalmologica|March 25, 2016
Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month studyKatja Hatz, Christian Prünte
The British Journal of Ophthalmology|January 13, 2016
Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degenerationKatja Hatz, Christian Prünte
Retina (Philadelphia, Pa.)|September 23, 2016
INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB: A Treat-and-Extend TrialKatja Hatz, Christian Prünte
The British Journal of Ophthalmology|November 20, 2013
Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab responseKatja Hatz, Christian Prünte
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 4, 2017
Baseline Optical Coherence Tomography Findings as Outcome Predictors after Switching from Ranibizumab to Aflibercept in Neovascular Age-Related Macular Degeneration following a Treat-and-Extend RegimenCengiz Türksever, Christian Prünte, Katja Hatz
European Journal of Ophthalmology|March 3, 2009
Intraindividual comparison of color perception and contrast sensitivity with and without a blue light-filtering intraocular lensRoman Eberhard, Pietro Roberti, Christian Prünte
Diabetes Research and Clinical Practice|February 13, 2017
Considerations for management of patients with diabetic macular edema: Optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaborationW David Strain, Xavier Cos, Christian Prünte
Current Eye Research|July 21, 2004
Measurement procedures in confocal choroidal laser Doppler flowmetryAlain Preitner, Selim Orgül, Christian Prünte, et al.
Retina (Philadelphia, Pa.)|March 15, 2017
ASSESSMENT OF DRUSEN AND OTHER RETINAL DEGENERATIVE CHANGES IN PATIENTS WITH HEREDITARY HEMOCHROMATOSISMoreno Menghini, Christian Prünte, Pierre A Krayenbuehl, et al.
European Journal of Ophthalmology|September 13, 2023
Relaxing radial retinal incisions for the treatment of persistent macular holesHanna Camenzind-Zuche, Lucas Janeschitz-Kriegl, Pascal Hasler, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Acta Ophthalmologica|March 25, 2016
Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month studyKatja Hatz, Christian Prünte
The British Journal of Ophthalmology|January 13, 2016
Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degenerationKatja Hatz, Christian Prünte
Retina (Philadelphia, Pa.)|September 23, 2016
INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB: A Treat-and-Extend TrialKatja Hatz, Christian Prünte
The British Journal of Ophthalmology|November 20, 2013
Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab responseKatja Hatz, Christian Prünte
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 4, 2017
Baseline Optical Coherence Tomography Findings as Outcome Predictors after Switching from Ranibizumab to Aflibercept in Neovascular Age-Related Macular Degeneration following a Treat-and-Extend RegimenCengiz Türksever, Christian Prünte, Katja Hatz
European Journal of Ophthalmology|March 3, 2009
Intraindividual comparison of color perception and contrast sensitivity with and without a blue light-filtering intraocular lensRoman Eberhard, Pietro Roberti, Christian Prünte
Diabetes Research and Clinical Practice|February 13, 2017
Considerations for management of patients with diabetic macular edema: Optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaborationW David Strain, Xavier Cos, Christian Prünte
Current Eye Research|July 21, 2004
Measurement procedures in confocal choroidal laser Doppler flowmetryAlain Preitner, Selim Orgül, Christian Prünte, et al.
Retina (Philadelphia, Pa.)|March 15, 2017
ASSESSMENT OF DRUSEN AND OTHER RETINAL DEGENERATIVE CHANGES IN PATIENTS WITH HEREDITARY HEMOCHROMATOSISMoreno Menghini, Christian Prünte, Pierre A Krayenbuehl, et al.
European Journal of Ophthalmology|September 13, 2023
Relaxing radial retinal incisions for the treatment of persistent macular holesHanna Camenzind-Zuche, Lucas Janeschitz-Kriegl, Pascal Hasler, et al.
Pageof 4